First child in UK trial receives skull-mounted epilepsy device, shows improvement

Oran, the first child in the UK to receive a skull-mounted epilepsy device in a clinical trial at Great Ormond Street Hospital, has seen a significant reduction in seizures after eight months. The CADET trial aims to recruit three more patients with Lennox-Gastaut syndrome before involving 22 participants. The device, targeting the thalamus, is rechargeable and offers hope for pediatric epilepsy treatment.